AI Science Tracker

REDMOD: pancreatic cancer signals in CT scans taken before diagnosis

Mayo Clinic · 29 Apr 2026 · medicine

Discovery

Mayo Clinic

REDMOD: pancreatic cancer signals in CT scans taken before diagnosis

Among nearly 2,000 abdominal CT scans originally considered normal, an AI radiomics model identified 73% of prediagnostic pancreatic cancers, with a median lead time of about 16 months. Validation included images from multiple institutions and protocols. This analysis used scans taken before diagnosis; clinical benefit and false positives in practice still need prospective evaluation.

Technology: REDMOD (Radiomics-based Early Detection Model)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: REDMOD was trained on 969 patients from a multi-institutional cohort and tested on an independent set of 493 patients (63 pre-diagnostic), with external specificity checks on further datasets and a comparison with radiologists; AUC 0.82 and 73.0% sensitivity, versus 38.9% for radiologists.
  • Still unknown: The article states that prospective validation in high-risk cohorts is the necessary next step; no explicit limitations section.
  • AI role: A fully automated radiomics framework with AI segmentation and an ensemble classifier on a 40-feature signature from standard-of-care CT scans.

Evidence sources: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-ai-detects-pancreatic-cancer-up-to-3-years-before-diagnosis-in-landmark-validation-study/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1136/gutjnl-2025-337266&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.